美国抛弃式注射器市场规模、份额、趋势分析报告：按产品、按应用、细分市场预测，2024-2030

美国抛弃式注射器市场成长与趋势

Grand View Research, Inc.的最新报告显示，到2030年，美国抛弃式注射器市场规模预计将达到36.9亿美元。

预测期内复合年增长率预计为 5.5%。除了疫苗需求的增加之外，自我给药的日益普及、安全注射器的日益普及以及技术的进步正在支持美国抛弃式注射器市场的成长。

SARS-CoV-2 大流行显着增加了对医院用品、急救用品、医疗耗材和药品的需求。由于 COVID-19，COVID-19 疫苗的产量增加，对美国製造的抛弃式注射器的需求也增加。 2020 年 1 月，生物医学高级研究与开发局 (BARDA) 预测，光在美国就需要 6.5 亿至 8.5 亿支针头和注射器用于疫苗接种。因此，COVID-19疫情对医用抛弃式注射器市场产生了重大影响，被认为是美国抛弃式注射器市场非常有效的驱动因素。

展望未来，联合国儿童基金会 (UNICEF) 等组织的目标是到年终前购买 10 亿支注射器，用于在 COVID-19 设施国家进行 COVID-19 疫苗接种工作。所有这些注射器均属于世界卫生组织 (WHO) 批准的自动失效 (AD) 类型。因此，预计市场成长将在不久的将来加速。

美国抛弃式注射器市场报告亮点

• 依产品划分，抛弃式注射器市场分为传统注射器和安全注射器。 2023年，安全注射器细分市场占据最大份额，约为64.5%，由于该产品具有安全性和易用性等各种优势，预计在预测期内将出现显着增长。
• 依应用来看，由于捐血意识不断增强，以及国内爱滋病感染疾病、结核疟疾、登革热等疾病盛行率上升，治疗注射器领域在2023年占据最大市场占有率，约86.2%。
• 预计加州抛弃式注射器市场在预测期内将呈现最快的成长速度。促进市场成长的因素包括老年人口的增加、手术数量的增加以及医疗保健支出的增加。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章抛弃式注射器市场变数、趋势、范围

• 市场体系展望
  • 母市场展望
  • 配套市场前景
• 渗透率和成长前景图
• 使用者观点分析
  • 消费行为分析
  • 市场影响者分析
• 主要最终用户名单
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 抛弃式注射器：市场分析工具
  • 产业分析-波特五力分析
  • SWOT 分析，透过 PEST
• COVID-19 对市场的影响和大流行后的前景

第四章美国抛弃式注射器市场：細項分析，按产品，2018-2030

• 定义和范围
• 2023 年及 2030 年产品市场占有率分析
• 细分仪表板
• 美国抛弃式注射器市场（按产品），2018-2030
• 2018-2030年市场规模及预测及趋势分析
• 传统注射器
• 安全注射器

第五章美国抛弃式注射器市场：細項分析（按应用），2018-2030

• 定义和范围
• 2023 年和 2030 年应用市场占有率分析
• 细分仪表板
• 2018-2030 年美国抛弃式注射器市场（按应用）
• 2018-2030年市场规模及预测及趋势分析
• 疫苗注射
• 治疗注射

第六章美国抛弃式注射器市场-竞争分析

• 主要市场参与企业的最新趋势和影响分析
• 公司分类
  • 创新者
  • 市场领导者
• 供应商情况
• 公司简介
  • Medtronic
  • Nipro Corporation
  • Fresenius Kabi Ag
  • Baxter International, Inc.
  • Braun Medical, Inc.
  • Becton, Dickinson And Company（Bd）
  • Flextronics International Vita Needle Company
  • Terumo Corporation
  • Novo Nordisk
  • Ultimed, Inc.
  • Henke-sass, Wolf
  • Retractable Technologies, Inc.

U.S. Disposable Syringes Market Growth & Trends:

The U.S. disposable syringes market size is expected to reach USD 3.69 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.5% CAGR over the forecast period. The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S. disposable syringes.

The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S. alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S. disposable syringes market.

Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

U.S. Disposable Syringes Market Report Highlights:

• On the basis of product, disposable syringes market has been segmented into conventional and safety syringes. Safety syringes segment held the largest share of around 64.5% in 2023 and is anticipated to witness a significant growth over the forecast period, owing to the various advantages, such as safety and easy to use, associated with this product.
• On the basis of application, the therapeutic injection segment held the largest market share of around 86.2% in 2023, owing to the increasing awareness towards blood donation and high prevalence of diseases such as HIV infection, tuberculosis malaria, and dengue in the country.
• California disposable syringes market is expected to witness the fastest growth rate over the forecast period. Factors that can be attributed to market growth include growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Product
  • 1.1.2 Application
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.7.1 Commodity Flow Analysis (Model 1)
    • 1.7.1.1 Approach 1: Commodity Flow Approach
  • 1.7.2 Volume Price Analysis (Model 2)
    • 1.7.2.1 Approach 2: Volume Price Analysis
• 1.7 List Of Secondary Sources
• 1.8 List Of Primary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective - 1
  • 1.10.2 Objective - 2
  • 1.10.3 Objective - 3
  • 1.10.4 Objective - 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 Disposable Syringes Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 User Perspective Analysis
  • 3.3.1 Consumer Behavior Analysis
  • 3.3.2 Market Influencer Analysis
• 3.4 List Of Key End Users
• 3.5 Market Dynamics
  • 3.5.1 Market Driver Analysis
    • 3.5.1.1 Increase In The Prevalence Of Chronic Diseases
    • 3.5.1.2 Increase In The Number Of Surgical Procedures
    • 3.5.1.3 Impact Of Covid-19 Outbreak
    • 3.5.1.4 Increasing Initiatives By Governments And Organizations
  • 3.5.2 Market Restraints Analysis
    • 3.5.2.1 Stringent Government Regulations
    • 3.5.2.2 Product Recalls
• 3.6 Disposable Syringes: Market Analysis Tools
  • 3.6.1 Industry Analysis - Porter's Five Forces
  • 3.6.2 Swot Analysis, By Pest
• 3.7 Impact Of Covid-19 On Market & Post Pandemic Insights

Chapter 4 U.S. Disposable Syringes Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 Definition And Scope
• 4.2 Product Market Share Analysis, 2023 & 2030
• 4.3 Segment Dashboard
• 4.4 U.S. Disposable Syringes Market, By Product, 2018 To 2030
• 4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 4.5.1 Conventional Syringes
    • 4.5.1.1 Conventional Syringes Market, 2018 - 2030 (USD Million)
  • 4.5.2 Safety Syringes
    • 4.5.2.1 Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.5.2.1.1 Retractable Safety Syringes
    • 4.5.2.1 1.1 Retractable Safety Syringes Market, 2018 - 2030 (USD Million)
    • 4.5.2.1.2 Non-retractable Safety Syringes
    • 4.5.2.1.2.1 Non-retractable Safety Syringes Market, 2018 - 2030 (USD Million)

Chapter 5 U.S. Disposable Syringes Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 5.1 Definition And Scope
• 5.2 Application Market Share Analysis, 2023 & 2030
• 5.3 Segment Dashboard
• 5.4 U.S. Disposable Syringes Market, By Application, 2018 To 2030
• 5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
  • 5.5.1 Immunization Injections
    • 5.5.1.1 Immunization Injections Market, 2018 - 2030 (USD Million)
  • 5.5.2 Therapeutic Injections
    • 5.5.2.1 Therapeutic Injections Market, 2018 - 2030 (USD Million)

Chapter 6 U.S. Disposable Syringes Market - Competitive Analysis

• 6.1 Recent Developments & Impact Analysis, By Key Market Participants
• 6.2 Company Categorization
  • 6.2.1 Innovators
  • 6.2.2 Market Leaders
• 6.3 Vendor Landscape
  • 6.3.1 Key Company Market Share Analysis, 2021
  • 6.3.2 Major Deals And Strategic Alliances
    • 6.3.2.1 New Product Launch
    • 6.3.2.2 Expansion
    • 6.3.2.3 Acquistion
  • 6.3.3 Market Entry Strategies
• 6.4 Company Profiles
  • 6.4.1 Medtronic
    • 6.4.1.1 Company Overview
    • 6.4.1.2 Financial Performance
    • 6.4.1.3 Product Benchmarking
    • 6.4.1.4 Strategic Initiatives
  • 6.4.2 Nipro Corporation
    • 6.4.2.1 Company Overview
    • 6.4.2.2 Financial Performance
    • 6.4.2.3 Product Benchmarking
    • 6.4.2.4 Strategic Initiatives
  • 6.4.3 Fresenius Kabi Ag
    • 6.4.3.1 Company Overview
    • 6.4.3.2 Financial Performance
    • 6.4.3.3 Product Benchmarking
    • 6.4.3.4 Strategic Initiatives
  • 6.4.4 Baxter International, Inc.
    • 6.4.4.1 Company Overview
    • 6.4.4.2 Financial Performance
    • 6.4.4.3 Product Benchmarking
    • 6.4.4.4 Strategic Initiatives
  • 6.4.5 Braun Medical, Inc.
    • 6.4.5.1 Company Overview
    • 6.4.5.2 Financial Performance
    • 6.4.5.3 Product Benchmarking
    • 6.4.5.4 Strategic Initiatives
  • 6.4.6 Becton, Dickinson And Company (Bd)
    • 6.4.6.1 Company Overview
    • 6.4.6.2 Financial Performance
    • 6.4.6.3 Product Benchmarking
    • 6.4.6.4 Strategic Initiatives
  • 6.4.7 Flextronics International Vita Needle Company
    • 6.4.7.1 Company Overview
    • 6.4.7.2 Financial Performance
    • 6.4.7.3 Product Benchmarking
    • 6.4.7.4 Strategic Initiatives
  • 6.4.8 Terumo Corporation
    • 6.4.8.1 Company Overview
    • 6.4.8.2 Financial Performance
    • 6.4.8.3 Product Benchmarking
    • 6.4.8.4 Strategic Initiatives
  • 6.4.9 Novo Nordisk
    • 6.4.9.1 Company Overview
    • 6.4.9.2 Financial Performance
    • 6.4.9.3 Product Benchmarking
    • 6.4.9.4 Strategic Initiatives
  • 6.4.10 Ultimed, Inc.
    • 6.4.10.1 Company Overview
    • 6.4.10.2 Financial Performance
    • 6.4.10.3 Product Benchmarking
    • 6.4.10.4 Strategic Initiatives
  • 6.4.11 Henke-sass, Wolf
    • 6.4.11.1 Company Overview
    • 6.4.11.2 Financial Performance
    • 6.4.11.3 Product Benchmarking
  • 6.4.12 Retractable Technologies, Inc.
    • 6.4.12.1 Company Overview
    • 6.4.12.2 Financial Performance
    • 6.4.12.3 Product Benchmarking
    • 6.4.12.4 Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. disposable syringes market, by product, 2018 - 2030 (USD Million)
• Table 4 U.S. disposable syringes market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Disposable syringes market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2021)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Disposable syringes market: Product movement analysis
• Fig. 19 Segment dashboard
• Fig. 20 Disposable syringes market product outlook: Key takeaways
• Fig. 21 Conventional syringes market, 2018 - 2030 (USD Million)
• Fig. 22 Safety syringes market, 2018 - 2030 (USD Million)
• Fig. 23 Retractable safety syringes market, 2018 - 2030 (USD Million)
• Fig. 24 Non-retractable safety syringes market, 2018 - 2030 (USD Million)
• Fig. 25 Disposable syringes market: Application movement analysis
• Fig. 26 Segment dashboard
• Fig. 27 Disposable syringes market application outlook: Key takeaways
• Fig. 28 Immunization injections market, 2018 - 2030 (USD Million)
• Fig. 29 Therapeutic injections market, 2018 - 2030 (USD Million)
• Fig. 30 Company market share analysis, 2021
• Fig. 31 Market differentiators